Considerations for the Design and Conduct of Clinical Trials for Hepatitis C

Date: 28 Aug. 2012  |  Topic: Study Experience

Unravel Hepatitis C and Ensure Clinical Trial Success Part of a new white paper series from PPD

"Considerations for the Design and Conduct of Clinical Trials for Hepatitis C" explores the nuances of the hepatitis C virus (HCV) that continue to impact the treatment strategies for the disease. PPD experts take a detailed look at the disease and break down the elements of a successful HCV study, including:

Learn more about PPD’s HCV and infectious disease expertise or contact us to share your feedback. 

Additional Materials

Contact Site Map Legal Notices Privacy Policy

© 2017 Pharmaceutical Product Development, LLC. All rights reserved.

Google+